Patients researching TMS often encounter two protocol variations — Unilateral TMS and Bilateral TMS. Both are used for major depression, but they work slightly differently and are chosen for different patient profiles. This guide explains Unilateral vs Bilateral TMS treatment for major depression, when each is used, and what the evidence suggests.
At Mind Brain Institute, we prescribe medication when it’s clinically indicated and select the specific TMS protocol based on individual clinical assessment.
What is Unilateral TMS?
Unilateral TMS therapy stimulates only one side of the brain — typically the left dorsolateral prefrontal cortex (DLPFC), which is consistently underactive in depression. Using high-frequency (typically 10 Hz) pulses, the treatment aims to strengthen this underactive region.
Unilateral TMS for depression is the standard, most-studied protocol. It’s what patients receive in most FDA-approved trials of rTMS for major depression.
What is Bilateral TMS?
Bilateral TMS therapy stimulates both sides of the brain in the same session — typically high-frequency stimulation to the left DLPFC (to activate the underactive region) combined with low-frequency (typically 1 Hz) stimulation to the right DLPFC (to reduce activity in an area often overactive in depression).
The rationale is that depression involves a dysfunction of both sides — underactivity on the left, overactivity on the right — and correcting both simultaneously may produce better outcomes for some patients.
What is the difference between Unilateral and Bilateral TMS?
Practically:
Feature | Unilateral | Bilateral |
|---|---|---|
Sides stimulated | One (usually left) | Both |
Frequencies | High (typically 10 Hz) | High on left, low on right |
Session length | Approximately 20–40 min | Slightly longer |
Evidence base | Larger, more established | Growing, less extensive |
Cost | Standard | May be slightly higher |
Best studied for | Standard major depression | Some evidence of benefit for treatment-resistant depression |
Is Unilateral or Bilateral TMS better for major depression?
This is a nuanced question and the honest answer is: it depends on the patient.
Unilateral TMS has the largest evidence base and is generally the first choice for most patients with major depressive disorder. Response rates in treatment-resistant depression are approximately 50–60%.
Bilateral TMS may offer additional benefit for some patients — particularly those who haven’t responded to unilateral TMS, or those with certain symptom profiles suggesting right-hemisphere hyperactivity (severe rumination, chronic anxiety-with-depression).
Head-to-head comparisons show modest differences overall, with individual variation. Bilateral protocols may produce faster onset in some patients but do not consistently produce dramatically better final outcomes.
When is Unilateral TMS recommended for depression?
Typical first-line choice for:
- Standard major depressive disorder without prominent anxiety features
- First-time TMS patients
- Patients who prefer shorter sessions
- Cost-sensitive patients
When is Bilateral TMS recommended for depression?
Considered for:
- Patients who haven’t responded to a Unilateral TMS course
- Depression with significant right-hemisphere features (rumination, hyperarousal)
- Some clinicians prefer bilateral for atypical or mixed features depression
- Patients where individualised assessment (potentially including QEEG) suggests bilateral targeting may help
What a Bilateral TMS session looks like
At Mind Brain Institute in Delhi, a typical Bilateral TMS session:
- Patient sits in a comfortable chair, awake
- The coil is first positioned over the left DLPFC for high-frequency stimulation (approximately 15–20 minutes)
- Then repositioned over the right DLPFC for low-frequency stimulation (approximately 15 minutes)
- Total session time: approximately 30–40 minutes
- No sedation, no recovery period needed
How many sessions are needed?
Both Unilateral and Bilateral protocols typically involve 20 to 30 sessions over 4 to 6 weeks. Some patients continue with periodic maintenance sessions afterwards.
Cost considerations
Bilateral TMS may be slightly more expensive per session than Unilateral due to the longer session time. However, if bilateral produces better response for a specific patient, the total cost may be more favourable in the long run — fewer courses over time.
At MBI, both protocols are offered based on clinical fit rather than commercial preference.
The decision-making process
Choosing between Unilateral and Bilateral TMS involves:
- Full psychiatric assessment
- Review of prior treatment history (medications, therapy, any prior TMS)
- Assessment of symptom profile (which features are prominent)
- Sometimes QEEG brain mapping to guide targeting
- Discussion of options with the patient
- Ongoing monitoring during the course; adjustment if needed
For a broader look at the treatment landscape, see our companion post on understanding TMS treatment of depression based on biotypes.
FAQ
What is the difference between unilateral and bilateral TMS?
Unilateral TMS stimulates one side of the brain (usually the left DLPFC). Bilateral TMS stimulates both sides — high-frequency on the left and low-frequency on the right — in the same session.
Is unilateral or bilateral TMS better for major depression?
Unilateral has the largest evidence base and is typically first-line. Bilateral may offer additional benefit for select patients — particularly those with certain symptom profiles or who haven’t responded to unilateral TMS.
How does unilateral TMS work for depression?
It strengthens the underactive left DLPFC using high-frequency magnetic stimulation, gradually restoring healthier activity in mood-regulation circuits.
When is bilateral TMS recommended for depression?
When a patient hasn’t responded to unilateral TMS, or when their symptom profile suggests both hemispheres are involved (significant rumination, chronic hyperarousal).
How many TMS sessions are needed for major depression?
Standard course: 20 to 30 sessions over 4 to 6 weeks. Accelerated protocols (SAINT) can compress this to 5 days for eligible patients.
